期刊文献+

核因子-кB诱骗寡核苷酸增强阿霉素对肝癌耐药细胞化疗敏感性的机制 被引量:6

A double-strand decoy DNA oligonucleotides of NF-κB induced the apoptosis and sensitization of hepatic cancer cells to chemotherapy
原文传递
导出
摘要 目的研究核因子(NF)-кB诱骗(decoy)寡核苷酸对肝癌耐药细胞株HepG2/阿霉素(ADM)化疗敏感性的影响及其内在机制。方法培养肝癌耐药细胞株,转染FITC标记的NF-кB decoy寡核苷酸,通过荧光显微镜和共聚焦显微镜进行核内定位的观察,凝胶迁移率实验检测转染前后NF-кB结合活性的变化,加入ADM,噻唑蓝(MTT)比色法检测细胞增殖,采用流式细胞仪和TUNEL法检测细胞凋亡,观察转染NF-кB decoy寡核苷酸后肝癌耐药细胞对化疗药物的敏感性变化,DEVD-pNA降解法检测Caspase-3的活性变化,Western blot检测bcl-2蛋白表达的变化。结果转染荧光标记的NF-кB decoy寡核苷酸1 h,倒置荧光显微镜和共聚焦显微镜显示定位于细胞核内,凝胶阻滞分析实验(EMSA)分析示NF-кB decoy寡核苷酸能够降低NF-кB核内结合,加入化疗ADM(0.1 mg/L)后,ADM作用24 h后出现细胞凋亡,流式细胞术、TUNEL法检测NF-кB decoy寡核苷酸转染HepG2/ADM细胞的凋亡,与对照组相比,凋亡指数增加,Caspase-3的活性增加,bcl-2的表达下调。结论NF-кB decoy寡核苷酸转染肝癌耐药细胞株HepG2/ADM后,能够抑制NF-кB的激活,Caspase-3活性增加和bcl-2的表达下调是其增加化疗药物的敏感性的可能机制。 Objective To investigate a double-stranded decoy oligodeoxynueleotides (ODNs) with a speeifie affinity to NF-κB effeetively suppressed NF-κB aetivity and sensitized hepatie eaneer eells to ehemotherapy. Methods HepG2 eells resistanting to adriamyein (HepG2/ADR) were indueed stepwised,FITC-labeled decoy ODNs against NF-κB were transfeeted into HepG2/ADR eells with LipofectAMINE^TM2000, Inverse fluoreseent mieroseopand showed the localization of decoy DNA, and EMSA was performated to investigate the affinity of NF-κB. ADM (0.1 mg/L) was added, the apoptosis was observed by flow eytometry and TUNEL differently. The aetivity of easpase3 was found by quantitative assay,the expression of bel-2 protein was deteeted by western blot. Results HepG2/ADR was confirmed resisting to ADM. When decoy ODNs was transfeeted, after 1 hour, FITC-labeled decoy ODNs against NF-κB was deteeted in the nuclei of HepG2/ADM eells, and eleetrophoretie mobility shift assays (EMSA) was performed to found the aetivation of NF-κB binding to the nueleus was inhibitd. Ineubed with ADM (0.1 mg/L) ,it showed signifieant inhibitory effeet on the growth of HepG2/ADM,the pereentage of apoptosis was increased compare with control at 24 h,easpase3 activity was inereased,bel-2 expression was downregulated. Conclusion Our findings suggest that decoy ODNs for NF-κB could be a novel and attractive strategy to improve treatment outcome of human hepatocarcinoma,bcl-2 and caspase3 could play important role during decoy ODNs inducing apoptosis.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2006年第9期1075-1078,共4页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金(30400431)
关键词 核因子-ΚB 化学治疗 耐药 CASPASE-3 肝细胞 NF-κB Chemotherapy Drug resistance Caspase-3 Carcinoma, hepatocellular
  • 相关文献

参考文献10

  • 1Cyert MS. Regulation of nuclear localization during signaling. J Biol Chem,2001,276:20805-20808.
  • 2Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB. J Clin Invest,2001,107:241-246.
  • 3Chiao PJ, Na R, Niu J, et al. Role of Rel/NF-κB transcription factors in apoptosis of human hepatocenular carcinoma cens. Cancer, 2002, 95:1696-1705.
  • 4王其,陈孝平,张万广,张必翔.人肝癌HepG2多药耐药细胞系的部分生物学性状研究[J].中华实验外科杂志,2004,21(5):538-540. 被引量:40
  • 5Zandi E, Karin M. Bridging the gap: composition, regulation, and physiological function of the IkappaB kinase complex. Mol Cell Biol, 1999,19:4547-4551.
  • 6Bentires AM, Barbu V, Fillet M, et al. NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene, 2003,22 : 90-97.
  • 7Hideshima T, Chauhan D, Schlossman R, et al. The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications. Oncogene, 2001,20:4519-4527.
  • 8Taylor ST,Hickman JA,Dive C. Epigenetic determinants of resistanceto etoposide regulation of bcl-X(L) and bax by tumor mieroenvironmental factors. J Natl Cancer Inst, 2000,92 : 18-23.
  • 9Jo N, Ogata N, Aoki M, et al. Effective transfection of a cis element "decoy"of the nuclear factor-κB binding site into the experimental choroidal neovascularlzation. Curr Eye Res, 2002,24:465-473
  • 10Mitsiades N, Mitsiades CS, Poulaki V, et al. Molecular sequelae of proteasome inhibition in human multiple myeloma cells. Proc Natl Acad Sci USA, 2002,99 : 14374-14379.

二级参考文献1

共引文献39

同被引文献79

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部